Insider filing · CPRX

Steve Miller sold $1.1M of Catalyst Pharmaceuticals (CPRX)

Executed Dec 10 2024, disclosed Dec 11 2024, 1 day later.

Returns are measured on stock purchases only.

SM Steve Miller Chief Op. & Scientific Officer profile →

Steve Miller (Chief Op. & Scientific Officer) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in CPRX. The largest single filing was $2.3M of CPRX (115,000 sh × $20.28, as filed), executed Aug 26 2025.

CPRX CPRX CPRX · 20 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→